Nanobac Pharmaceuticals, Incorporated NNBP OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

16/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Nanobac Pharmaceuticals, Incorporated (NNBP) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 15/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

16/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

7/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — NNBP

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
1996	$-1.93	$8.88M	$-1.24M	-14%
1997	$-2.42	$9.94M	$-1.91M	-19.2%
1998	$-1.21	$8.77M	$-2.68M	-30.5%
1999	$-1.23	$6.84M	$-2.74M	-40%
2002	$-0.04	$11.56K	$-1.48M	-12767.6%
2003	$-0.05	$482.82K	$-3.7M	-766.2%
2004	$-0.05	$358.36K	$-7.87M	-2197.4%
2005	$-0.02	$656.8K	$-3.69M	-561.4%
2006	$-0.02	$225.09K	$-4.97M	-2209.5%
2007	$0.00	$17.62K	$-6.58M	-37319.7%